Sector Chart Plus Therapeutics, Inc.

Stocks

PSTV

US72941H8060

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 10:38:01 2026-07-31 EDT			5-day change	1st Jan Change
3.630 ^USD	-0.55%		-5.22%	-71.66%

07-16	Plus Therapeutics, Inc. And Genomic Testing Cooperative, LCA Partner To Integrate Next-Generation Sequencing Into The CNSide CSF Assay Platform	CI
07-16	Plus Therapeutics, Genomic Testing Cooperative to Integrate NGS Technology Into CNSide CSF Assay Platform	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
PLUS THERAPEUTICS, INC.	25.12M			-	-	-
LONZA GROUP AG	49.37B
IQVIA HOLDINGS INC.	39.14B
REVOLUTION MEDICINES, INC.	40.85B	-	-	-	-	-
BEONE MEDICINES AG	35.81B
CELLTRION, INC.	30.5B